Cite
HARVARD Citation
Filizoglu, N. et al. (2022). 18F-FDG PET/CT Metabolic Response With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent 4/6 Kinase Inhibitors. Clinical nuclear medicine. pp. e605-e606. [Online].